Collaborations

Verndari is a member of the UC Davis Venture Catalyst. Verndari has a laboratory at the UC Davis Medical Center in Sacramento.

UC Davis is making their faculty, facilities, and resources available to members of its Venture Catalyst. This capability ranges from basic research facilities and services, to a GMP manufacturing facility. Verndari has relationships with several staff and faculty members at UC Davis. These include:

Emir Hodzic, PhD RT-qPCR Core
Kristin Grimsrud, PhD, DVM MBP Veterinary Services
Derek Cissell, PhD, DVM Veterinary School
Peter Barry, PhD Center for Comparative Medicine
William Chang, PhD, DVM Center for Comparative Medicine
Gerhard Bauer GMP Facility P1 and P2 materials
Steven Lucero TEAM Lab, Biomedical Engineering UCD

 

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

John H. Brown
President

John graduated with High Honors from Princeton in 1968 and received a Harvard MBA in 1970. He was Co-Head of Hamblet and Hayes from 1971 to 1980, when H&H was sold to CIBA-Geigy. During the next seventeen years John was with CIBA-Geigy (now renamed to Novartis), rising to become a Senior Vice President. During that period, he held many different positions including head of various points of Finance, Strategy, Business Development, Licensing, Policy, State and Federal Government Affairs, Pharmacoeconomics Research, QC/QA, Safety, Health, and Environment, and Regulatory Compliance. He also oversaw the over the counter business, CIBA-Corning Diagnostics, Biocine (a joint venture with Chiron in the Vaccine business), and the US Generics business.

After retiring from CIBA-Geigy, John was CEO of Covance Biotechnology Services, Inc., Research Triangle Park, NC, a contract manufacturer of Biopharma active ingredients (later sold to AKZO NOBEL), CEO of Integrated Biosystems, Inc., Napa, CA, a manufacturer of production equipment for Bio Pharmaceutical customers (e.g., Genentech, Amgen); (later sold to Stedim, SA, France); and President of Bausch & Lomb, London, where he oversaw Europe, Middle East & Africa. John had charge of the entire portfolio of eye care products (Surgical, Pharma, and Vision Care), representing around $2.5B in sales.

read more